Abstract There has been considerable progress in the medicinal chemistry of voltage-gated ion channels in the last decade. A number of targets within the family have the highest level of validation, namely, clinical validation. Recent advances in screening technologies have allowed medicinal chemistry programs to proceed rapidly and identify compounds which are currently undergoing clinical evaluation. Initial clinical results have been disappointing, but a number of compounds remain in active trials.